GTB: Its Advantage on Research, Drug Pipelines and Patents

The Greater Tokyo Biocommunity (GTB) was established in October 2021 to strengthen the bioindustry ecosystem and achieve the goal of “realizing the world’s most advanced bioeconomy society by 2030,” as stated in the national government’s “Bioeconomy Strategy 2020“. GTB promotes the formation of a global biocommunity hub in Tokyo and its surrounding areas (hereafter referred to as the “greater Tokyo area”), with the participation of a total of 45 organizations including local governments, universities, research institutes, bio-related organizations, industry support organizations, and financial and investment institutions. In April of this year, the GTB received accreditation as a global bio-community from the national government, and is on the verge of accelerating […]

GTB: Its Advantage on Research, Drug Pipelines and Patents Read More »